BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7641213)

  • 1. Re: M. D. Dabholkar et al., Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261-1266, 1995.
    Panasci L; McQuillan A; Malapetsa A; Christodoulopoulos GR
    Cancer Res; 1995 Sep; 55(17):3933-4. PubMed ID: 7641213
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2.
    Dabholkar MD; Berger MS; Vionnet JA; Egwuagu C; Silber JR; Yu JJ; Reed E
    Cancer Res; 1995 Mar; 55(6):1261-6. PubMed ID: 7882319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide excision repair protein levels vis-à-vis anticancer drug resistance in 60 human tumor cell lines.
    Chen ZP; Malapetsa A; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Panasci LC
    Ai Zheng; 2002 Mar; 21(3):233-9. PubMed ID: 12451985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.
    Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS
    Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors.
    Evans E; Moggs JG; Hwang JR; Egly JM; Wood RD
    EMBO J; 1997 Nov; 16(21):6559-73. PubMed ID: 9351836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [XPD (ERCC2) (Xeroderma pigmentosum, group D). Reparation gene].
    Bull Cancer; 1998 Dec; 85(12):987-8. PubMed ID: 9988553
    [No Abstract]   [Full Text] [Related]  

  • 7. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
    Boulikas T
    Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes.
    Vogel U; Nexø BA; Tjønneland A; Wallin H; Hertel O; Raaschou-Nielsen O
    Mutat Res; 2006 Jan; 593(1-2):88-96. PubMed ID: 16054657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk.
    Kuschel B; Chenevix-Trench G; Spurdle AB; Chen X; Hopper JL; Giles GG; McCredie M; Chang-Claude J; Gregory CS; Day NE; Easton DF; Ponder BA; Dunning AM; Pharoah PD
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1828-31. PubMed ID: 16030124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the expression of DNA excision repair biomarkers in cispatin-treated lung cancer cell line].
    Wang ZY; Zhou S; Lu B; Zhang X; Hao QL; Zhou YK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):109-11. PubMed ID: 12839662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of DNA repair genes: ERCC1 G19007A and ERCC2/XPD C22541A in a northeastern Chinese population.
    Yin J; Li J; Vogel U; Wang H
    Biochem Genet; 2005 Oct; 43(9-10):543-8. PubMed ID: 16341770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
    J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraneuronal monoamine transporter expression and DNA repair vis-à-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines.
    Chen ZP; Remack J; Brent TP; Mohr G; Panasci LC
    Clin Cancer Res; 1999 Dec; 5(12):4186-90. PubMed ID: 10632359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.
    Dabholkar M; Vionnet J; Bostick-Bruton F; Yu JJ; Reed E
    J Clin Invest; 1994 Aug; 94(2):703-8. PubMed ID: 8040325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between ERCC2 polymorphisms and gliomas.
    Caggana M; Kilgallen J; Conroy JM; Wiencke JK; Kelsey KT; Miike R; Chen P; Wrensch MR
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):355-60. PubMed ID: 11319176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of normal DNA repair and mutagenesis in trichothiodystrophy cells after transduction of the XPD human gene.
    Marionnet C; Quilliet X; Benoit A; Armier J; Sarasin A; Stary A
    Cancer Res; 1996 Dec; 56(23):5450-6. PubMed ID: 8968100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas.
    Liang BC; Ross DA; Reed E
    J Neurooncol; 1995 Oct; 26(1):17-23. PubMed ID: 8583241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.
    Aloyz R; Xu ZY; Bello V; Bergeron J; Han FY; Yan Y; Malapetsa A; Alaoui-Jamali MA; Duncan AM; Panasci L
    Cancer Res; 2002 Oct; 62(19):5457-62. PubMed ID: 12359753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human xeroderma pigmentosum group D gene encodes a DNA helicase.
    Sung P; Bailly V; Weber C; Thompson LH; Prakash L; Prakash S
    Nature; 1993 Oct; 365(6449):852-5. PubMed ID: 8413672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients.
    Dabholkar M; Bostick-Bruton F; Weber C; Bohr VA; Egwuagu C; Reed E
    J Natl Cancer Inst; 1992 Oct; 84(19):1512-7. PubMed ID: 1433335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.